Author:
Bertrand Kerri,Sepulveda Yadira,Spiegel Benjamin J.,Best Brookie M.,Suhandynata Raymond,Rossi Steven,Chambers Christina D.,Momper Jeremiah D.
Abstract
Impact
Findings from this study provide further reassuring evidence that infant exposure through human milk received from lactating individuals who require treatment with remdesivir is negligible.
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Hollier, L. Covid-19, Pregnancy, Childbirth, and Breastfeeding: Answers from Ob-Gyns https://www.acog.org/womens-health/faqs/coronavirus-covid-19-pregnancy-and-breastfeeding#:~:text=Pregnant%20and%20postpartum%20women%20have,prenatal%20and%20postpartum%20care%20visits (2022).
2. Jorgensen, S. C. J., Kebriaei, R. & Dresser, L. D. Remdesivir: review of pharmacology, pre-clinical data, and emerging clinical experience for Covid-19. Pharmacotherapy: J. Hum. Pharmacol. Drug Ther. 40, 659–671 (2020).
3. Medicine, N. L. O. Drugs and Lactation Database (LactMed) Vol. 2022 (National Institute of Child Health and Human Development, 2006).
4. Pace, R. M. et al. Covid-19 and human milk: SARS-CoV-2, antibodies, and neutralizing capacity. medRxiv https://doi.org/10.1101/2020.09.16.20196071 (2020).
5. WHO. Breastfeeding and Covid-19: Scientific Brief (WHO, 2020).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献